I am currently a 2nd year mbbs student and i have my preliminary examination going on and today is my pathology theory examination. I will upload photo of my question paper. Answer according to the marking scheme. Use simple language like a student is writing it. Use diagrams and flow charts wherever needed. Refer to the standard textbooks

Please go ahead and upload the photo of your question paper! Once you share it, I'll analyze it and answer all questions according to the marking scheme using simple, student-friendly language with diagrams and flowcharts where needed.
analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here are complete answers to all questions in your paper. Written simply, as a student would write in an exam.

PATHOLOGY THEORY EXAMINATION - COMPLETE ANSWERS


SECTION B


Q.2 — Breast Tumours (10 Marks)

(Classify + Risk factors + Gross & Microscopic features of Carcinoma Breast)

A) Classification of Breast Tumours

BREAST TUMOURS
│
├── BENIGN
│   ├── Fibroadenoma (most common benign tumour)
│   ├── Phyllodes tumour (benign variant)
│   ├── Intraductal papilloma
│   ├── Fat necrosis
│   └── Fibrocystic change (not a true tumour)
│
└── MALIGNANT (Carcinoma)
    │
    ├── NON-INVASIVE (In situ)
    │   ├── Ductal Carcinoma In Situ (DCIS) - most common
    │   └── Lobular Carcinoma In Situ (LCIS)
    │
    └── INVASIVE (Infiltrating)
        ├── Invasive Ductal Carcinoma (IDC) - 70-80% of all carcinomas
        │   └── Scirrhous / NOS type
        ├── Invasive Lobular Carcinoma (ILC) - 10-15%
        ├── Medullary Carcinoma
        ├── Mucinous (Colloid) Carcinoma
        ├── Tubular Carcinoma
        ├── Papillary Carcinoma
        ├── Paget's Disease of the nipple
        └── Inflammatory Carcinoma

B) Risk Factors for Carcinoma Breast

Hormonal Risk Factors (most important):
  • Early menarche (before 12 years)
  • Late menopause (after 55 years)
  • Nulliparity / late first pregnancy (after 30 years)
  • Prolonged use of oral contraceptives / HRT
  • Obesity (especially post-menopausal - adipose tissue produces estrogen)
Genetic / Family History:
  • BRCA1 mutation - risk of breast + ovarian cancer
  • BRCA2 mutation - risk of breast cancer (also in males)
  • Family history in first-degree relatives
  • Li-Fraumeni syndrome (TP53 mutation)
Other Risk Factors:
  • Previous benign breast disease with atypia (atypical ductal hyperplasia)
  • Radiation exposure to chest
  • High fat diet, alcohol consumption
  • Previous carcinoma in opposite breast
RISK FACTOR SUMMARY
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Increased ESTROGEN exposure → KEY MECHANISM
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

C) Gross Features of Carcinoma Breast (IDC - Scirrhous type)

  • Size: Variable, usually 1-5 cm
  • Shape: Irregular, stellate (star-shaped)
  • Consistency: Hard, stony (rock-like) due to dense fibrous stroma - hence called "scirrhous"
  • Cut surface: Grey-white, chalky white streaks (due to calcification)
  • Borders: Irregular, ill-defined - infiltrates surrounding fat
  • Skin changes: Skin dimpling, nipple retraction (due to fibrosis pulling ligaments of Cooper)
  • Peau d'orange: Skin looks like orange peel due to lymphatic obstruction (in inflammatory type)

D) Microscopic Features of Carcinoma Breast (IDC)

  • Malignant ductal epithelial cells arranged in:
    • Cords, nests, and clusters
    • Tubule formation (gland-like structures)
    • Indian-file pattern (in lobular carcinoma - single cells in a line)
  • Stroma: Abundant fibrous (desmoplastic) stroma - "hard" consistency
  • Nuclear features: Large, pleomorphic nuclei, prominent nucleoli, frequent mitoses
  • Necrosis: Comedo necrosis in DCIS (central necrosis within ducts)
  • Calcification: Dystrophic calcifications may be present
  • Lymphovascular invasion: Common in aggressive tumours
  • ER/PR/HER2 status - assessed by immunohistochemistry
DCIS Microscopy:
Malignant cells filling ductal lumen
+ Central comedo necrosis
+ No invasion through basement membrane

IDC Microscopy:
Malignant cells BREAKING THROUGH basement membrane
+ Invading stroma
+ Desmoplastic reaction
(Reference: Robbins & Kumar Basic Pathology)


Q.3 — Any Five Clinical Scenarios (5 × 3 = 15 Marks)


Q3-A: 45-year-old obese female with itching, RUQ colicky pain

(Serum bilirubin 12 mg/dl, Conjugated bilirubin 10 mg/dl, ALP 450 U/L, AST 70, ALT 80)
Diagnosis: Obstructive Jaundice (Cholestatic jaundice) - Most likely due to Choledocholithiasis (common bile duct stone)
Interpretation of Investigations:
TestValueInterpretation
Total Bilirubin12 mg/dl (↑↑)Hyperbilirubinemia
Conjugated (Direct) Bilirubin10 mg/dl (↑↑)Predominantly conjugated = post-hepatic/obstructive jaundice
ALP450 U/L (↑↑↑)Marker of biliary obstruction - markedly elevated
AST70 U/L (mildly ↑)Mild hepatocellular damage
ALT80 U/L (mildly ↑)Mild hepatocellular damage
Explanation:
  • High conjugated bilirubin → problem is AFTER the liver (bile cannot drain)
  • Very high ALP → classical of bile duct obstruction
  • Mildly elevated AST/ALT → secondary liver cell damage due to back-pressure
  • Itching (pruritus) → due to bile salts deposited in skin
  • RUQ pain → due to gallstone obstructing CBD
  • Obese female → classic risk factor (F, Fat, Forty, Fertile = gallstones)
FLOW: Gallstone blocks CBD → Bile cannot flow → 
Conjugated bilirubin regurgitates into blood → 
Jaundice + Itching + ALP rises markedly

Q3-B: 55-year-old male with chest pain, ST elevation and T-wave inversion

Diagnosis: Acute Myocardial Infarction (STEMI)
Cardiac Biomarkers and Their Timeline:
TIME AFTER MI ONSET
│
0 hours ─── Symptoms begin (chest pain, sweating)
│
1-3 hours ── Myoglobin rises (EARLIEST to rise, NOT cardiac specific)
│
3-6 hours ── Troponin I / Troponin T rises (EARLIEST specific marker)
│             CK-MB starts rising
│
12-24 hrs ── Troponin peaks
│             CK-MB peaks
│             LDH starts rising
│
24-48 hrs ── CK-MB returns to normal
│
3-7 days ─── Troponin T remains elevated (useful for LATE diagnosis)
│             LDH peaks
│
7-14 days ── LDH returns to normal
│
14 days ──── Troponin I returns to normal
BiomarkerRisesPeaksReturns to NormalNotes
Myoglobin1-3 hrs6-9 hrs24 hrsEarliest, not specific
CK-MB3-6 hrs12-24 hrs24-48 hrsSpecific for cardiac muscle
Troponin I3-6 hrs12-24 hrs5-10 daysGold standard
Troponin T3-6 hrs12-24 hrs10-14 daysGold standard
LDH24 hrs3-6 days8-14 daysUseful for late MI
Most important: Troponin I and T are the gold standard markers for MI - most sensitive and specific.

Q3-C: 14-year-old male, swelling around knee, X-ray shows destructive metaphyseal tumour with sunburst appearance

Diagnosis: Osteosarcoma
Gross Features:
  • Large, bulky tumour arising in metaphysis of distal femur / proximal tibia
  • Cut surface: grey-white to tan, gritty (due to bone formation)
  • Areas of haemorrhage and necrosis
  • Codman's triangle: Periosteum is lifted by tumour → reactive bone forms a triangular shell at edges (seen on X-ray)
  • Tumour breaks through cortex into soft tissue
  • Sunburst appearance on X-ray = tumour bone growing perpendicular to shaft through periosteum
Microscopic Features:
  • Malignant spindle-shaped osteoblasts (stromal cells)
  • Direct production of osteoid / tumour bone by malignant cells (ESSENTIAL for diagnosis)
  • High nuclear pleomorphism, frequent mitoses, atypical mitoses
  • Areas of cartilage may be present (chondroblastic osteosarcoma)
  • Fibroblastic areas also present
  • Necrosis common
  • Tumour invades surrounding soft tissue
KEY DIAGNOSTIC FEATURE = Malignant cells producing OSTEOID directly
(Reference: Robbins & Kumar Basic Pathology - Osteosarcoma section)

Q3-D: 40-year-old male with epigastric pain relieved by food, no vomiting or weight loss

Diagnosis: Duodenal Ulcer (Peptic Ulcer Disease)
Etiopathogenesis:
NORMAL BALANCE:
Aggressive factors ←→ Defensive factors
(acid, pepsin)         (mucus, bicarbonate, 
                        prostaglandins)

IN PEPTIC ULCER:
Aggressive > Defensive → MUCOSAL BREAKDOWN
Step-by-step Etiopathogenesis:
  1. H. pylori infection (most important cause - 90% of duodenal ulcers)
    • H. pylori colonizes gastric antrum
    • Produces urease → splits urea to ammonia → damages mucosa
    • Causes antral gastritis → decreases somatostatin → increased gastrin → increased acid production
    • Produces vacuolating toxin (VacA) and CagA → damages epithelium
  2. Increased acid production:
    • H. pylori → antral gastritis → ↑ gastrin → ↑ HCl
    • Increased parietal cell mass
    • Rapid gastric emptying → acid load in duodenum
  3. Decreased mucosal defense:
    • NSAID use → inhibits COX → decreased prostaglandins → decreased mucus & bicarbonate
    • H. pylori disrupts mucus layer
  4. Pain relieved by food = because food buffers the acid (typical of duodenal ulcer)
    • (Gastric ulcer pain is typically worse after eating)
Other contributing factors: Smoking, alcohol, stress (Cushing ulcer = brain injury; Curling ulcer = burns)

Q3-E: 6-year-old male child with massive proteinuria, hypoalbuminemia, generalized oedema, hyperlipidaemia

Diagnosis: Nephrotic Syndrome
Causes of Nephrotic Syndrome:
CAUSES
├── PRIMARY (Renal disease)
│   ├── Minimal Change Disease (MCD) - MOST COMMON in children (90%)
│   ├── Focal Segmental Glomerulosclerosis (FSGS)
│   ├── Membranous Nephropathy (most common in adults)
│   └── Membranoproliferative GN (MPGN)
│
└── SECONDARY (Systemic disease)
    ├── Diabetes Mellitus (Diabetic nephropathy)
    ├── Systemic Lupus Erythematosus (SLE)
    ├── Amyloidosis
    ├── Infections (Malaria, Hepatitis B/C, HIV)
    └── Drugs (Gold, Penicillamine, NSAIDs)
In this child (6 years old): Most likely Minimal Change Disease (Lipoid Nephrosis)
  • Most common cause of nephrotic syndrome in children
  • Responds well to steroids
Pathogenesis of Features:
Loss of negative charge on GBM (podocyte damage)
        ↓
Massive PROTEINURIA (>3.5 g/day)
        ↓
Low plasma proteins (Hypoalbuminemia)
        ↓
Low oncotic pressure → fluid leaks into interstitium
        ↓
GENERALIZED OEDEMA (pitting oedema, ascites, pleural effusion)
        ↓
Compensatory: ↑ lipoprotein synthesis by liver
        ↓
HYPERLIPIDAEMIA + LIPIDURIA

Q3-F: 48-year-old male, chronic smoker, haemoptysis and weight loss

Sequence from Squamous Metaplasia to Squamous Cell Carcinoma of Lung:
NORMAL BRONCHIAL EPITHELIUM
(Pseudostratified ciliated columnar epithelium)
        ↓
Repeated exposure to cigarette smoke carcinogens
        ↓
STEP 1: BASAL CELL HYPERPLASIA
(Proliferation of basal cells)
        ↓
STEP 2: SQUAMOUS METAPLASIA
(Columnar cells replaced by squamous cells - reversible if smoking stopped)
        ↓
STEP 3: SQUAMOUS DYSPLASIA
(Nuclear atypia, loss of polarity, abnormal mitoses)
        ↓
STEP 4: CARCINOMA IN SITU (CIS)
(Full thickness dysplasia, basement membrane INTACT)
        ↓
Accumulation of mutations: TP53, RB, KRAS, loss of 3p
        ↓
STEP 5: INVASIVE SQUAMOUS CELL CARCINOMA
(Cells breach basement membrane, invade stroma)
        ↓
Presents with: HAEMOPTYSIS (central tumour erodes vessels)
               Weight loss (cancer cachexia)
Morphology of Squamous Cell Carcinoma:
  • Arises centrally (near bronchi)
  • Keratin pearls + intercellular bridges on microscopy
  • Cavitation common
  • Associated with PTHrP secretion → hypercalcaemia (paraneoplastic)


Q.4 — Any Four Out of Five (4 × 5 = 20 Marks)


Q4-A: Renal Function Tests

Glomerular Function Tests:
TestNormal ValueSignificance
Serum Creatinine0.6 - 1.2 mg/dlBest single indicator of GFR
Blood Urea Nitrogen (BUN)7 - 20 mg/dlRises in renal failure
BUN : Creatinine ratio10:1 to 20:1Pre-renal >20:1; Renal 10:1
GFR (Creatinine clearance)90-120 ml/minGold standard for GFR
Serum Uric Acid3.5-7.2 mg/dlElevated in gout, renal disease
Tubular Function Tests:
TestNormalSignificance
Urinary specific gravity1.003-1.030Concentrating ability
Urine osmolality50-1200 mOsm/kgDiluting/concentrating ability
Urine sodiumVariesLow (<20 mEq/L) in pre-renal
Fractional excretion of Na (FENa)<1% pre-renal; >2% renalDistinguishes pre-renal vs ARF
Other Tests:
  • Urinalysis: Protein, glucose, casts (RBC casts = glomerulonephritis; WBC casts = pyelonephritis; granular casts = ATN)
  • Serum electrolytes: Na, K, HCO3 - hyperkalemia and acidosis in renal failure
  • Urine protein: 24-hour urine protein >3.5 g/day = nephrotic range
GFR Estimation (CKD-EPI or MDRD formula) uses serum creatinine, age, sex, race.
CKD STAGING BY GFR:
Stage 1: GFR ≥ 90 (normal/increased)
Stage 2: GFR 60-89 (mildly reduced)
Stage 3: GFR 30-59 (moderately reduced)
Stage 4: GFR 15-29 (severely reduced)
Stage 5: GFR <15 (kidney failure/ESRD)

Q4-B: Etiology and CSF Findings in Pyogenic Meningitis

Etiology (by age group):
AGE GROUP        COMMON ORGANISMS
─────────────────────────────────────────────────────
Neonates         Group B Streptococcus (#1)
(0-3 months)     E. coli, Listeria monocytogenes

Infants/Children Neisseria meningitidis (#1)
(3 months - 18y) Streptococcus pneumoniae
                 Haemophilus influenzae (now rare - vaccine)

Adults (18-60y)  Streptococcus pneumoniae (#1)
                 Neisseria meningitidis

Elderly (>60y)   Streptococcus pneumoniae (#1)
                 Listeria monocytogenes
                 Gram-negative bacilli

Immunocompromised Any of above + Listeria + Gram negatives
CSF Findings in Pyogenic Meningitis:
ParameterNormalPyogenic Meningitis
AppearanceClear, colourlessTurbid / Cloudy / Purulent
Pressure70-180 mmH₂OIncreased (↑↑)
Cells (Pleocytosis)0-5 lymphocytes1000-10000 cells/mm³ - Predominantly NEUTROPHILS (PMN)
Protein20-40 mg/dlMarkedly increased (100-500 mg/dl)
Glucose45-85 mg/dl (>60% of serum)Markedly decreased (<45 mg/dl)
CSF:Serum glucose ratio>0.6<0.4
Gram stainNegativePositive in 70-80% cases
CultureNegativePositive (gold standard)
LactateLowElevated
MEMORY AID for Pyogenic Meningitis CSF:
↑ Pressure
↑ Turbid (cloudy)
↑ Neutrophils
↑ Protein
↓ Glucose

Q4-C: Malignant Melanoma - Sites, Gross and Microscopic Features

Sites:
  • Skin - most common (anywhere but especially: back in men, legs in women)
  • Specific types by site:
    • Superficial spreading melanoma - most common type (70%) - trunk/extremities
    • Nodular melanoma - most aggressive - back, trunk
    • Lentigo maligna melanoma - face (elderly, sun-exposed skin)
    • Acral lentiginous melanoma - palms, soles, subungual (under nails) - most common in dark-skinned individuals
  • Other sites: eye (uveal melanoma), mucous membranes, meninges
Gross Features:
  • Asymmetrical lesion (use ABCDE rule: Asymmetry, Border irregularity, Colour variation, Diameter >6mm, Evolution)
  • Colours: brown, black, tan, red, white, pink - variable colours
  • Irregular, notched borders
  • May ulcerate and bleed
  • Nodular type: raised, dome-shaped nodule, deeply pigmented, rapidly growing
  • May show satellite lesions
  • Thickness (Breslow thickness) measured in mm - most important prognostic factor
Microscopic Features:
  • Melanocytes showing marked pleomorphism
  • Large cells with abundant cytoplasm containing melanin granules
  • Prominent large eosinophilic (red) nucleoli - "owl-eye nucleoli"
  • High mitotic rate
  • Radial growth phase: tumour spreads horizontally in epidermis
  • Vertical growth phase: tumour invades dermis (poor prognosis)
  • Pagetoid spread: single melanoma cells scattered in epidermis
  • Lymphocytic infiltrate at base
  • Clark's levels: measured by depth of invasion (Levels I-V)
  • Breslow thickness: measured from granular layer to deepest tumour cell

Q4-D: Differences between Crohn's Disease and Ulcerative Colitis

FeatureCrohn's DiseaseUlcerative Colitis
LocationAny part of GI tract (mouth to anus)Colon only (rectum to cecum)
PatternSkip lesions (discontinuous)Continuous from rectum
RectumOften sparedAlways involved (starts here)
ExtentEntire bowel wall (transmural)Mucosa and submucosa only
GrossCobblestone appearance, fissuresPseudopolyps, granular mucosa
StricturesCommon ("string sign" on X-ray)Rare
FistulaeCommon (enterocutaneous, enterovesical)Rare
MicroscopyNon-caseating granulomasNo granulomas - crypt abscesses, goblet cell depletion
UlcersDeep, knife-like fissuring ulcersShallow mucosal ulcers
WallThickened, "rubber hose" appearanceThinned in severe cases
BleedingLess commonCommon (rectal bleeding hallmark)
Cancer riskSlightly increasedMarkedly increased (pancolitis >10 years)
SmokingWorsens diseaseProtective (paradoxically)
p-ANCANegativePositive in 70%
ASCAPositive (anti-Saccharomyces)Negative

Q4-E: Renal Cell Carcinoma

Definition: Malignant tumour arising from tubular epithelium of the kidney. Also called hypernephroma or Grawitz tumour.
Types:
  • Clear cell RCC (most common, 70-80%) - VHL gene mutation
  • Papillary RCC (10-15%)
  • Chromophobe RCC (5%)
  • Collecting duct carcinoma (rare, most aggressive)
Risk factors: Smoking (#1 acquired), obesity, hypertension, Von Hippel-Lindau disease, adult polycystic kidney disease
Gross Features:
  • Usually in upper pole of kidney
  • Large, solitary, spherical mass
  • Cut surface: bright yellow to orange (due to lipid and glycogen in clear cells)
  • Areas of haemorrhage, necrosis, cystic change
  • Well-demarcated by a pseudocapsule
  • May extend into renal vein → IVC → right atrium (tumour thrombus)
Microscopic Features (Clear Cell type):
  • Large cells with clear cytoplasm (lipid and glycogen washed out in processing)
  • Cells arranged in sheets, nests, tubules or alveolar pattern
  • Prominent vascular stroma (very vascular tumour)
  • Small round dark nuclei (low grade) to large pleomorphic nuclei (high grade)
  • Thin-walled blood vessels between tumour cells
Classic Clinical Triad (found in only 10% of cases):
1. Haematuria (blood in urine)
2. Flank pain
3. Palpable flank mass
Paraneoplastic syndromes:
  • Polycythaemia (ectopic EPO)
  • Hypercalcaemia (PTHrP)
  • Hypertension (ectopic renin)
  • Cushing syndrome (ectopic ACTH)


Q.5 — Any Three (3 × 5 = 15 Marks)


Q5-A: Gross and Microscopic Features of Lobar Pneumonia

Definition: Acute bacterial infection affecting an entire lobe of the lung. Most common organism: Streptococcus pneumoniae (Pneumococcus).
The 4 Stages of Lobar Pneumonia:
STAGE 1: CONGESTION (0-24 hrs)
• Gross: Lobe heavy, red, congested, boggy
• Micro: Vascular congestion, oedema fluid in alveoli
         Few bacteria, few neutrophils in alveolar spaces
         Alveolar septa stretched

         ↓

STAGE 2: RED HEPATIZATION (2-3 days)
• Gross: Lobe solid, firm, red, airless - like liver (hepatization)
         Red colour due to RBCs
• Micro: Alveoli packed with NEUTROPHILS, RBCs, and fibrin
         Capillaries congested
         Bacteria present

         ↓

STAGE 3: GREY HEPATIZATION (4-8 days)
• Gross: Lobe still solid/firm but grey-white colour
         Grey colour = RBCs disintegrate, fibrin dominates
• Micro: Alveoli filled with FIBRIN meshwork
         Neutrophils (many dead/disintegrating)
         No RBCs (lysed)
         Macrophages appear

         ↓

STAGE 4: RESOLUTION (8-10 days)
• Gross: Lobe returns to normal appearance
         Softening of exudate
• Micro: Macrophages digest fibrin and debris
         Alveolar architecture restored
         Lung returns to normal (if uncomplicated)
Complications: Carnification (organization of exudate), abscess, empyema, bacteraemia, meningitis

Q5-B: Leiomyoma Uterus (Fibroid)

Definition: Benign tumour of smooth muscle of the uterus. Most common tumour in females. Also called fibromyoma or fibroid.
Sites:
UTERINE LEIOMYOMA - LOCATIONS
├── Intramural (most common) - within myometrium
├── Submucosal - under endometrium, projects into uterine cavity
│   → Causes MOST SEVERE menorrhagia + infertility
├── Subserosal - under peritoneum, projects outward
│   → May become pedunculated
└── Cervical - rare
    Broad ligament - rare
Gross Features:
  • Multiple (multiple fibroids in 75% of cases), well-circumscribed, firm tumours
  • Whorled, trabeculated grey-white cut surface
  • Clearly demarcated from surrounding myometrium by a pseudocapsule
  • Size varies from millimetres to >20 cm
  • Hard, rubbery consistency
Microscopic Features:
  • Interlacing bundles of smooth muscle cells arranged in whorls
  • Cells are spindle-shaped with cigar-shaped (blunt-ended) nuclei
  • Uniform, bland nuclei - NO atypia, NO necrosis, NO mitoses (distinguishes from malignant leiomyosarcoma)
  • Cells have abundant eosinophilic cytoplasm
  • Fibrous connective tissue between bundles
  • May show secondary changes: hyaline degeneration (most common), cystic, red (carneous), fatty, calcification, malignant change (rare, <1%)
Clinical features: Menorrhagia, pelvic pain, infertility, pressure symptoms; Oestrogen-sensitive (grows in reproductive age, regresses after menopause)

Q5-C: Papillary Carcinoma of the Thyroid

Definition: Most common thyroid malignancy (80-85% of all thyroid cancers). Arises from follicular epithelial cells.
Gross Features:
  • Usually unilateral, single nodule
  • Often infiltrative, ill-defined borders (unlike follicular carcinoma)
  • May be multifocal (20%)
  • Cut surface: grey-white, firm, granular
  • Psammoma bodies may be felt as gritty areas
  • Foci of calcification
  • Cystic change sometimes present
  • May spread to cervical lymph nodes early (but prognosis still excellent)
Microscopic Features - DIAGNOSTIC:
DIAGNOSTIC FEATURES OF PAPILLARY CARCINOMA:

1. PAPILLARY architecture
   - Papillae with fibrovascular core
   - Lined by 1-2 layers of tumour cells
   (BUT papillary pattern not essential for diagnosis)

2. NUCLEAR FEATURES (MOST IMPORTANT):
   ┌─────────────────────────────────────────┐
   │ • Optically clear ("Orphan Annie eye")  │
   │   nuclei - "ground glass" / empty look  │
   │ • Nuclear grooves (coffee bean nuclei)  │
   │ • Intranuclear cytoplasmic inclusions   │
   └─────────────────────────────────────────┘
   These nuclear features = DIAGNOSTIC hallmark

3. PSAMMOMA BODIES
   - Concentric calcified laminated bodies
   - Present in 40-50% of cases
   - Pathognomonic when combined with papillary features

4. Follicular structures may also be present
Behaviour: Spreads via lymphatics (to cervical nodes). Haematogenous spread is late. Excellent prognosis (>95% 10-year survival). Associated with radiation exposure and RET/PTC gene rearrangements.

Q5-D: Laboratory Diagnosis of Diabetes Mellitus

Diagnostic Criteria (WHO / ADA):
DIABETES MELLITUS - LABORATORY DIAGNOSIS
─────────────────────────────────────────────────────────────
Test             Normal      Pre-diabetes    Diabetes
─────────────────────────────────────────────────────────────
Fasting Blood    <100        100-125         ≥ 126 mg/dl
Glucose (FBG)    mg/dl       (IFG)

2-hr Post OGTT   <140        140-199         ≥ 200 mg/dl
(75g glucose)    mg/dl       (IGT)

Random Blood     -           -               ≥ 200 mg/dl
Glucose                                      + symptoms

HbA1c            <5.7%       5.7-6.4%        ≥ 6.5%
─────────────────────────────────────────────────────────────
Tests Used:
  1. Fasting Blood Glucose (FBG): Patient fasts for 8 hours. ≥126 mg/dl on TWO occasions = DM
  2. OGTT (Oral Glucose Tolerance Test): 75g oral glucose given; blood glucose measured at 0, 1, 2 hours. 2-hour value ≥200 = DM. (Gold standard for gestational DM)
  3. Random Blood Glucose: Any time of day. ≥200 mg/dl WITH classic symptoms (polyuria, polydipsia, weight loss) = DM
  4. HbA1c (Glycated Haemoglobin): Reflects average blood glucose over past 2-3 months. ≥6.5% = DM. Used for monitoring AND diagnosis.
  5. Urine Glucose (Glucosuria): Appears when blood glucose >180 mg/dl (renal threshold). Not diagnostic alone but a screening test.
  6. Urine Ketones: Positive in DKA (Type 1 DM mainly)
  7. C-peptide: Distinguishes Type 1 (low/absent C-peptide) from Type 2 (normal/high C-peptide)
  8. Insulin assay: Helpful in research/classification
  9. Microalbuminuria (spot urine ACR): 30-300 mg/g = early diabetic nephropathy
MONITORING DM:
HbA1c every 3 months - TARGET <7% (53 mmol/mol)


Q.6 — Short Notes (4 × 5 = 20 Marks)


Q6-A: Coal Workers' Pneumoconiosis (CWP)

Definition: Lung disease caused by inhalation of coal dust (carbon). Also called Black Lung disease or Anthracosis in simple form.
Types:
  1. Simple CWP (most common) - coal macules and nodules, usually asymptomatic
  2. Complicated CWP / Progressive Massive Fibrosis (PMF) - large fibrotic masses, severe lung damage
Pathogenesis:
Inhalation of coal dust particles (<5 µm reach alveoli)
        ↓
Phagocytosed by ALVEOLAR MACROPHAGES
        ↓
Macrophages cannot digest carbon → accumulate
        ↓
Release: Cytokines (IL-1, TNF), Reactive Oxygen Species
        ↓
FIBROSIS (collagen deposition)
        ↓
COAL MACULES (dust + macrophages around respiratory bronchioles)
        ↓
COAL NODULES (macules + fibrosis)
        ↓
PROGRESSIVE MASSIVE FIBROSIS (PMF) in heavy exposure
Gross Features:
  • Lungs are black (anthracotic pigmentation)
  • Simple CWP: Coal macules (1-2 mm, soft, black) + coal nodules (up to 2 cm, harder) - predominantly in upper lobes
  • PMF: Large black fibrotic masses (>2 cm, up to >10 cm) - upper/central lung
  • Emphysema around macules (focal emphysema)
  • Pleural anthracosis
Microscopic Features:
  • Carbon-laden macrophages in clusters
  • Coal nodules: Aggregates of dust-laden macrophages + haphazardly arranged collagen
  • PMF: Dense collagen + coal dust pigment + areas of necrosis
  • Emphysematous spaces surrounding nodules
Complications: Pulmonary hypertension, cor pulmonale, respiratory failure Note: CWP + Rheumatoid arthritis = Caplan's syndrome (large rheumatoid nodules in lungs)

Q6-B: Osteomyelitis

Definition: Inflammation of bone due to infection. Most commonly bacterial.
Routes of infection:
1. Haematogenous spread (most common in children)
   - Bacteria in blood → seeds metaphysis (rich blood supply, sluggish flow)
   
2. Direct spread from contiguous focus
   - Trauma, surgery, bite wounds
   
3. Direct inoculation
   - Open fractures, orthopaedic procedures
Common organisms:
  • Staphylococcus aureus - most common at ALL ages
  • Neonates: Group B Streptococcus, E. coli
  • Children: H. influenzae (rare now), S. aureus
  • Sickle cell patients: Salmonella (unique)
  • Diabetics/immunocompromised: Gram-negatives, fungi
Location in children: Metaphysis of long bones (distal femur, proximal tibia, proximal humerus) - rich vascular supply, sluggish blood flow = bacteria settle here
Gross Features (Acute):
  • Bone is red, congested, oedematous
  • Pus formation in medullary cavity
  • Involucrum: New bone formed by periosteum around dead bone (shell of living bone)
  • Sequestrum: Dead devascularized bone fragment (grey-white, separated from living bone)
  • Cloaca: Opening in involucrum through which pus discharges
  • Sinus tract: Channel through soft tissue/skin for pus drainage
Microscopic Features:
  • Acute: Neutrophilic infiltration, necrosis, vascular congestion
  • Chronic: Lymphocytes, plasma cells, macrophages, fibrosis, new bone formation, necrotic bone (sequestrum)
SEQUESTRUM → Dead bone
INVOLUCRUM → New bone around it
CLOACA → Hole in involucrum
SINUS TRACT → External drainage pathway

Q6-C: Seminoma

Definition: Most common testicular germ cell tumour (GCT), arising from primordial germ cells (spermatogonia). Peak age: 30-40 years.
Gross Features:
  • Testis enlarged, smooth surface
  • Cut surface: Homogeneous, lobulated, grey-white ("cream cheese" appearance)
  • Well-defined borders, lobulated by fibrous septa
  • No haemorrhage or necrosis (unlike non-seminomatous GCTs)
  • Replaces testicular parenchyma
  • Tunica albuginea usually intact
Microscopic Features:
CLASSIC APPEARANCE:
• Large, uniform, round cells with:
  - Clear/pale cytoplasm (abundant glycogen - PAS positive)
  - Large central nucleus
  - Prominent nucleoli
  - Well-defined cell borders

• Arranged in SHEETS and LOBULES
  separated by fibrous septa

• Fibrous septa infiltrated by LYMPHOCYTES
  (important diagnostic feature)

• Granulomatous reaction may be present
  (giant cells, histiocytes)

• NO trophoblastic cells, NO yolk sac elements
Tumour markers:
  • Placental ALP (PLAP) - elevated in 90% of cases
  • β-hCG - elevated in 15-20% (syncytiotrophoblast cells)
  • AFP - NEGATIVE (if AFP raised → not pure seminoma, mixed GCT)
  • LDH - non-specific, raised
Important points:
  • Radiosensitive (unlike non-seminomatous GCTs)
  • Excellent prognosis even in advanced stages
  • Spreads via lymphatics to para-aortic lymph nodes first
  • Associated with cryptorchidism (undescended testis)

Q6-D: Ethical Issues Pertaining to Consent for Surgical Procedures

Informed consent is a patient's right to receive adequate information and voluntarily agree to a procedure. It is both a legal requirement and an ethical obligation.
Key Ethical Principles:
4 PILLARS OF MEDICAL ETHICS
┌─────────────────┬────────────────────────────────────────────┐
│ Autonomy        │ Patient's right to make own decisions       │
│ Beneficence     │ Act in patient's best interest              │
│ Non-maleficence │ Do no harm                                  │
│ Justice         │ Fair treatment for all patients             │
└─────────────────┴────────────────────────────────────────────┘
Elements of Valid Informed Consent:
  1. Disclosure: Doctor must explain:
    • Nature of the diagnosis
    • Nature of the proposed procedure
    • Benefits and risks of the procedure
    • Alternatives available (including doing nothing)
    • Consequences of refusing treatment
  2. Comprehension: Patient must understand the information (use appropriate language, translator if needed)
  3. Voluntariness: Patient must decide freely - without coercion, pressure or undue influence
  4. Competence/Capacity: Patient must have the mental ability to make decisions (age >18 years; no severe mental illness; not under influence of drugs/alcohol)
Special Situations:
SituationEthical Approach
Minor (child <18 yrs)Consent from parent/guardian; assent from child if possible
Unconscious/EmergencyImplied consent - operate to save life
Mentally incapacitatedConsent from next of kin or legal guardian
Refusal of treatmentRespect patient's autonomy, document clearly
Research proceduresExtra strict consent + IRB/Ethics committee approval
Therapeutic privilegeWithholding info only if disclosure causes direct harm - controversial
Documentation: Consent form must be signed by patient + witness + surgeon. Oral consent alone is insufficient for major surgical procedures.
Ethical Issues:
  • Patient not given enough time to decide (rushed consent)
  • Consent obtained by junior doctors who may not explain fully
  • Language barriers → poor comprehension
  • Illiterate patients - verbal consent + thumb impression
  • Consent for teaching/photography requires additional consent
  • Post-operative complications not disclosed → medicolegal issues

All answers based on: Robbins & Kumar Basic Pathology, Bailey and Love's Surgery, Fishman's Pulmonary Diseases, and standard MBBS pathology curriculum. Good luck with your exam!
This is a shared conversation. Sign in to Orris to start your own chat.